Donald School Journal of Ultrasound in Obstetrics and Gynecology

Register      Login

VOLUME 10 , ISSUE 3 ( July-September, 2016 ) > List of Articles


Placenta Accreta: A Review of the Etiology, Diagnosis, and Management

Ivica Zalud, William Goh

Keywords : Accreta,Morbity adherent Placentation,Prenatal diagnosis

Citation Information : Zalud I, Goh W. Placenta Accreta: A Review of the Etiology, Diagnosis, and Management. Donald School J Ultrasound Obstet Gynecol 2016; 10 (3):352-363.

DOI: 10.5005/jp-journals-10009-1484

License: CC BY-NC 4.0

Published Online: 01-09-2017

Copyright Statement:  Copyright © 2016; The Author(s).


How to cite this article

Goh W, Zalud I. Placenta Accreta: A Review of the Etiology, Diagnosis, and Management. Donald School J Ultrasound Obstet Gynecol 2016;10(3):352-363.

PDF Share
  1. Pregnancy related mortality in the United States, 1991-1997. Obstet Gynecol 2003;101: 289-297.
  2. Abnormal Placentation. Semin Perinatol 2009;33:88-96.
  3. Placenta Accreta and Postpartum Hemorrhage. Clin Ob/Gyn 2010;53(1):228-236.
  4. Obstet Gynecol 2002;99:169-170.
  5. Effect of predelivery diagnosis in 99 consecutive cases of placenta accreta. Obstet Gynecol 2010;115(1):65-69.
  6. Abnormal placentation: twenty year analysis. Am J Obstet Gynecol 2005;192:1458-1461.
  7. Clinical risk factors for placenta previa-placenta accreta. Am J Obstet Gynecol. 1997; 177:210-214.
  8. Placenta praevia and accreta: analysis of a two year experience. Gynecol Obstet Invest 1998;46:96-98.
  9. Maternal Morbidity Associated with Multiple Repeat Cesarean Deliveries. Obstet Gynecol 2006;107:1226-1232.
  10. The early sonographic appearance of placenta accreta. J Ultrasound Med 2003 Jan;22(1):19-23.
  11. Sonographic detection of placenta accreta in the second and third trimester. Am J Obstet Gynecol 2004;190(4):1135-1140.
  12. Color flow mapping for myometrial invasion in women with a prior cesarean delivery. J Matern Fetal Med 2000;9(6):330-335.
  13. Role of three-dimensional power Doppler in the antenatal diagnosis of placenta accreta: comparison with gray-scale and color Doppler techniques. Ultrasound Obstet Gynecol 2009;33:193-203.
  14. Prenatal diagnosis of placenta previa accreta by transabdominal color Doppler ultrasound. Ultrasound Obstet Gynecol 2000;15:28-35.
  15. Placenta accreta: Evaluation with Color Doppler US, Power Doppler US, and MR Imaging. Radiology 1997;205:773-776.
  16. The value of specific MRI features in the evaluation of suspected placenta accreta. Magn Reson Imagin 2007;25(1):87-93.
  17. Accuracy of ultrasonography and magnetic resonance imaging in the diagnosis of placenta accreta. Obstet Gynecol 2006;108(3):573-581.
  18. Prenatal diagnosis of placenta accreta: sonography or magnetic resonance imaging. J Ultrasound Med 2008;27(9):1275-1281.
  19. Abnormal placental invasion-a novel approach to tdreatment. Ob Gyn Survey 2009;64(12):811-822.
  20. Placenta accreat/ percreta/increta: a cause of elevated maternal serum alphafetoprotein. Obstet Gynecol 1992;80(4):63-64.
  21. Placenta accreta is associated with elevated maternal serum alpha-fetoprotein. Obstet Gynecol 1993;82(2):266-269.
  22. Risk factors for placenta accreta. Obstet Gynecol. 1999 Apr:93(4):545-550.
  23. Creatine kinase as a biochemical marker in diagnosis of placenta increta and percreta. Am J Obstet Gynecol. 1999 Apr;180(4):1039-1040.
  24. Increased cell-free fetal DNA in plasma of two women with Invasive Placenta. Clin Chem 2002;4(2):353-354.
  25. Increased level of cell-free placental mRNA in a subgroup of placentda previa. Prenat Diagn 2008;28(9):805-809.
  26. Cell-free placental mRNA in maternal plasma to predict placental invasion in patients with placenta accreta. Int J Gynecol Obstet 2010;109:30-33.
  27. Perinatal outcome of pregnancies complicated by placenta accreta. Obstet Gynecol 2004;104(3):527-530.
  28. Peripartum hysterectomy: 1999 to 2006. Obstet Gynecol 2008; 111(3):732-738.
  29. Optimal management strategies for placenta accreta. BJOG 2009;116(5):648-654.
  30. Emergency postpartum hemorrhage for uncontrolled postpartum bleeding. Obstet Gynecol 2010;115(3):637-644.
  31. Conservative versus extirpative management in cases of placenta accreta. Obstet Gynecol 2004;104(3):531-536.
  32. Reilly J, Moretti M, Pillari V. Argon beam coagulation in the management of placenta accreta. Obstet Gynecol 1999;94(2):825-827.
  33. B-Lynch suture, intrauterine ballon, and endouterine hemostatic suture for the management of postpartum hemorrhage due to placenta previa accreta. Int J Gynecol Obstet 2010;108(3):191-193.
  34. Maternal outcome after conservative treatment of placenta accreta. Obstet Gynecol 2010;115(3):526-534.
  35. Management of placenta accreta: morbidity and outcome. Eur J Obstet Gynecol Reprod Biol 2007;133(1):34-39.
  36. Conservative management of abnormally invasive placentation. Obstet Gynecol Surv 2007;62(8):529-539.
  37. Predictors of failed pelvic arterial embolization for severe postpartum hemorrhage. Obstet Gynecol 2009;113(5):992-999.
  38. Fertility and obstetric outcome after conservative management of placenta accreta. Int J Gynecol Obstet 2010:109(2):147-150.
  39. Surgical management of placenta accreta: a cohort series and suggested approach. Am J Obstet Gynecol 2010;202(1):28:e1-9.
  40. Anaesthetic management of placenta accreta: use of a pre-operative high and low suspicioun classification. Anaesthesia 2005;60:1079-1084.
  41. Anesthesia for the repeat cesarean section in the parturient with abnormal placentation: what does an obstetrician need to know? Arch Gynecol Obstet 2006;273(6): 319-321.
  42. Placenta percreta and the Urologist. Rev Urol 2009;11(3):173-176.
  43. Pathology of the human placenta. New York; Springer-Verlag 2006.
  44. Placental basal plate formation is associated with fibrin deposition in decidual veins at sites of trophoblastic cell invasion. Am J Obstet Gyneceol 2002;186(2):291-296.
  45. Occult Placenta Accreta: the missing link in the diagnosis of abnormal placentation. Ped Dev Path 2007;10:266-277.
  46. Placenta accreta: an immunohistologic study of trophoblast populations. Placenta. 1987 May-Jum;8(3):273-282.
  47. Differential Expression of Growth-, Angiogenesis- and Invasion-related Factors in the Development of Placenta Accreta. Taiwanese J Obstet Gynecol 2006;45(2): 100-105.
  48. Expression of epideral growth factor receptor and c-erbB-2 oncoprotein in trophoblast populations of placenta accreta. Am J Obstet Gynecol 2004;191: 2106-2113.
  49. Differential expression of vascular endothelial growth factor, placenta growth factor and their receptors in placentae from pregnancies complicated by placaenta accreta. Placenta 2006;27:70-78.
  50. Differential expression of angiopoietin-1, angiopoietin-2 and Tie receptors in placentas from pregnancies complicated by placenta accreta. Am J Obstet Gynecol 2006;194:564-571.
  51. Metalloproteinases and human placenta invasiveness. Placenta 2006;27:783-793.
  52. Marix metalloproteinases-2, -3 and -9 in human term placenta. Acta histochemica 2007;109:403-412.
  53. Expression and importance of matrix metalloproteinase 2 and 9 (MMP-2 and -9) in human trophoblast invasion. Reprod Biol Endocrinol 2004;2:59.
  54. Decidual NK cells alter in vitro first trimester extravillous cytotrophoblast migration: a role for IFN-gamma. J Immunol 2006;15:177(12):8522-8530.
  55. Human decidual relaxin and preterm birth. Ann. N Y Acad Sci 2005;1041:338-344.
  56. Early placental insulinlike protein (INSL4 or EPIL) in placental and fetal membrane growth. Biol Reprod 2005;73:695-702.
  57. Relaxin, its receptor (RXFP1), and insulin-like peptide 4 expression through gestation and in placenta accreta. Reprod Sci 2013;20(8):968-980.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.